NCT04985851 2023-12-01
To Evaluate the Efficacy of Durvalumab + Anlotinib in Terms of OS and PFS.
Shanghai Chest Hospital
Phase NA Unknown
Clinical Trials
13 trialsNCT05490667 2023-10-30
Clinical Study of Anlotinib Combined With Chemotherapy in the Treatment of Unresectable Advanced Desmoid Tumor
Henan Cancer Hospital
Phase NA Unknown
NCT06015126 2023-08-29
Efficacy and Safety of Metronomic Oral Vinorelbine Plus Anlotinib in HER2-negative Metastatic Breast Cancer Patients
Xi'an International Medical Center Hospital
Phase NA Unknown
NCT05385900 2022-05-23
ICTCPTLAGC
Xijing Hospital
Phase NA Unknown
NCT05218759 2022-02-01
Exosomes Detection for the Prediction of the Efficacy and Adverse Reactions of Anlotinib in Patients With Advanced NSCLC
Shanghai Chest Hospital
Phase NA Unknown
NCT04813406 2021-03-24
Study of Anlotinib Plus Sintilimab in the Treatment of Advanced Esophageal Squamous Cell Carcinoma
Henan Provincial People's Hospital
Phase NA Unknown
NCT04731909 2021-02-10
Toripalimab Combined With Anlotinib, Etoposide and Platinum in the Treatment of Extensive-stage Small Cell Lung Cancer
Third Military Medical University
Phase NA Unknown
NCT04471480 2020-07-15
TC
Third Military Medical University
Phase NA Unknown
NCT03769805 2019-10-22
CSOAIMTOAN
The First Affiliated Hospital with Nanjing Medical University
Phase NA Unknown
NCT03929965 2019-04-29
Anlotinib in Advanced Solid Tumors With FGFR Alteration
Shanghai Changzheng Hospital
Phase NA Unknown
NCT03766776 2018-12-11
ATAHC
The First Affiliated Hospital with Nanjing Medical University
Phase NA Unknown
NCT03671538 2018-09-17
Non Squamous NSCLC Patients With Anlotinib Combined With Pemetrexed and Cisplatin
The First Affiliated Hospital of Nanchang University
Phase NA Unknown
NCT03602027 2018-07-26
Phase I Study of the Combination of Anlotinib With Gefitinib
Second Affiliated Hospital of Nanchang University
Phase NA Unknown